Projects per year
Personal profile
Education
- 2005-2009 Ph.D., Graduate Institute of Pharmacy, Taipei Medical University
- 2003-2005 M.S., Graduate Institute of Pharmacognosy, Taipei Medical University
- 1998-2003 B.S., School of Chemical Engineering, Yuan-Ze University
Experience
- 2019.08- Professor, Department of Biochemistry and Molecular Cell Biology, School of Medicine, College of Medicine, Taipei Medical University
- 2019.01- Director, Department of Biochemistry and Molecular Cell Biology, School of Medicine, College of Medicine, Taipei Medical University
- 2017.08- Associate Professor, Research Center of Cell Therapy and Regeneration Medicine, Taipei Medical University
- 2016.02-2019.07 Associate Professor, Department of Biochemistry and Molecular Cell Biology, Taipei Medical University
- 2014.08-2016.01 Assistant Professor, Department of Biochemistry and Molecular Cell Biology, Taipei Medical University
- 2012.10-2014.07 Assistant Professor, Department of Biochemistry and Molecular Cell Biology, Taipei Medical University
- 2012.08-2012.09 Assistant Researcher, Department of Biochemistry and Molecular Cell Biology, Taipei Medical University
- 2010.07-2012.08 Postdoctoral Research Scholar, Academia Sinica
- 2009 Postdoctoral Fellow, Academia Sinica
Research Interests
- Biochemistry, Molecular Biology, Oncology, Signal Transduction
Fingerprint
Dive into the research topics where Cheng-Wei Lin is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
探討DDX3對粒線體自噬之分子調控機制以及對三陰性乳癌幹細胞特性與抗藥性之角色(1/3)
8/1/23 → 7/31/24
Project: A - Government Institution › b - National Science and Technology Council
-
探討在慢性阻塞性肺病由PM2.5造成肺氣腫的潛在ITIH缺失之分子機轉型 －探討PM2.5導致慢性阻塞性肺病中ITIH與粒線體代謝壓力之間的相互關係與分子調控機制(2/3)
8/1/23 → 7/31/24
Project: A - Government Institution › b - National Science and Technology Council
-
探討褪黑激素改善Olaparib抗藥性之調控機制及對三陰性乳癌的治療效果
7/1/23 → 2/29/24
Project: A - Government Institution › b - National Science and Technology Council
-
探討褪黑激素促進Olaparib對三陰性乳癌治療效果與調控機制
3/1/23 → 2/29/24
Project: C - Project of Alliance › o - Chi Mei Medical Center
-
Investigation of Molecular Mechanism and Crosstalk between Itih and Mitochondrial Metabolic Stress in Pm2.5-Associated Copd( I )
8/1/22 → 7/31/23
Project: A - Government Institution › b - National Science and Technology Council
-
Obesity-mediated upregulation of the YAP/IL33 signaling axis promotes aggressiveness and induces an immunosuppressive tumor microenvironment in breast cancer
Dai, J. Z., Yang, C. C., Shueng, P. W., Wang, Y. J., Huang, C. S., Chao, Y. C., Chen, C. H. & Lin, C. W., 2023, (Accepted/In press) In: Journal of Cellular Physiology. 238, 5, p. 992-1005 14 p.Research output: Contribution to journal › Article › peer-review
-
3-Nitrobenzanthrone promotes malignant transformation in human lung epithelial cells through the epiregulin-signaling pathway
Chen, K. Y., Tseng, C. H., Feng, P. H., Sun, W. L., Ho, S. C., Lin, C. W., Van Hiep, N., Luo, C. S., Tseng, Y. H., Chen, T. T., Liu, W. T., Lee, K. Y. & Wu, S. M., 2022, In: Cell Biology and Toxicology. 38, 5, p. 865-887 23 p.Research output: Contribution to journal › Article › peer-review
3 Citations (Scopus) -
Corrigendum: Heparin binding epidermal growth factor–like growth factor is a prognostic marker correlated with levels of macrophages infiltrated in lung adenocarcinoma(Front. Oncol., (2022), 12, (963896), 10.3389/fonc.2022.963896)
Van Hiep, N., Sun, W. L., Feng, P. H., Lin, C. W., Chen, K. Y., Luo, C. S., Dung, L. N., Van Quyet, H., Wu, S. M. & Lee, K. Y., Dec 13 2022, In: Frontiers in Oncology. 12, 1106553.Research output: Contribution to journal › Comment/debate › peer-review
Open Access -
Heparin binding epidermal growth factor–like growth factor is a prognostic marker correlated with levels of macrophages infiltrated in lung adenocarcinoma
Van Hiep, N., Sun, W. L., Feng, P. H., Lin, C. W., Chen, K. Y., Luo, C. S., Dung, L. N., Van Quyet, H., Wu, S. M. & Lee, K. Y., Nov 10 2022, In: Frontiers in Oncology. 12, 963896.Research output: Contribution to journal › Article › peer-review
Open Access1 Citation (Scopus) -
Lnc-IL7R alleviates PM2.5-mediated cellular senescence and apoptosis through EZH2 recruitment in chronic obstructive pulmonary disease
Lee, K. Y., Ho, S. C., Sun, W. L., Feng, P. H., Lin, C. W., Chen, K. Y., Chuang, H. C., Tseng, C. H., Chen, T. T. & Wu, S. M., 2022, (Accepted/In press) In: Cell Biology and Toxicology.Research output: Contribution to journal › Article › peer-review
7 Citations (Scopus)